Download PDF
Semin intervent Radiol 2018; 35(05): 469-476
DOI: 10.1055/s-0038-1676343
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Long Chronic Total Occlusions: Revascularization Strategies

Daniel Sheeran
1   Division of Vascular and Interventional Radiology, Department of Radiology and Medical Imaging, University of Virginia Health System, Charlottesville, Virginia
,
Luke R. Wilkins
1   Division of Vascular and Interventional Radiology, Department of Radiology and Medical Imaging, University of Virginia Health System, Charlottesville, Virginia
› Author Affiliations
Further Information

Publication History

Publication Date:
05 February 2019 (online)

Also available at
    Permissions and Reprints

Abstract

The treatment of chronic total occlusions (CTO) in patients with peripheral arterial disease (PAD) is a complex topic with multiple treatment techniques and treatment strategies. The interventionalist treating patients with PAD should have both a defined treatment algorithm and multiple techniques available for crossing these challenging lesions. This article will cover techniques for treating CTOs and provide an overview of current available evidence.

Keywords

chronic total occlusion - peripheral arterial disease - angioplasty - stent - interventional radiology - recanalization
 

  • References

  • 1 Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res 2015; 116 (09) 1509-1526
    CrossrefPubMedGoogle Scholar
  • 2 Hirsch AT, Haskal ZJ, Hertzer NR. , et al; American Association for Vascular Surgery; Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC/AHA Task Force on Practice Guidelines; American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; Vascular Disease Foundation. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 2006; 47 (06) 1239-1312
    CrossrefPubMedGoogle Scholar
  • 3 Weitz JI, Byrne J, Clagett GP. , et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 1996; 94 (11) 3026-3049
    PubMedGoogle Scholar
  • 4 Sleight P. The HOPE study (Heart Outcomes Prevention Evaluation). J Renin Angiotensin Aldosterone Syst 2000; 1 (01) 18-20
    CrossrefPubMedGoogle Scholar
  • 5 Kumbhani DJ, Steg PG, Cannon CP. , et al; REACH Registry Investigators. Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry. Eur Heart J 2014; 35 (41) 2864-2872
    CrossrefPubMedGoogle Scholar
  • 6 van der Heijden FH, Eikelboom BC, Banga JD, Mali WP. Management of superficial femoral artery occlusive disease. Br J Surg 1993; 80 (08) 959-963
    CrossrefPubMedGoogle Scholar
  • 7 Adam DJ, Beard JD, Cleveland T. , et al; BASIL Trial Participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005; 366 (9501): 1925-1934
    CrossrefPubMedGoogle Scholar
  • 8 Bradbury AW, Adam DJ, Bell J. , et al; BASIL Trial Participants. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg 2010; 51 (5, Suppl): 5S-17S
    CrossrefPubMedGoogle Scholar
  • 9 Davaine JM, Azéma L, Guyomarch B. , et al. One-year clinical outcome after primary stenting for Trans-Atlantic Inter-Society Consensus (TASC) C and D femoropopliteal lesions (the STELLA “STEnting Long de L'Artère fémorale superficielle” cohort). Eur J Vasc Endovasc Surg 2012; 44 (04) 432-441
    CrossrefPubMedGoogle Scholar
  • 10 Hardman RL, Jazaeri O, Yi J, Smith M, Gupta R. Overview of classification systems in peripheral artery disease. Semin Intervent Radiol 2014; 31 (04) 378-388
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Conte MS, Pomposelli FB, Clair DG. , et al; Society for Vascular Surgery Lower Extremity Guidelines Writing Group; Society for Vascular Surgery. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. J Vasc Surg 2015; 61 (3, Suppl): 2S-41S
    CrossrefPubMedGoogle Scholar
  • 12 Davies MG, El-Sayed HF. Outcomes of native superficial femoral artery chronic total occlusion recanalization after failed femoropopliteal bypass. J Vasc Surg 2017; 65 (03) 726-733
    CrossrefPubMedGoogle Scholar
  • 13 Han DK, Shah TR, Ellozy SH, Vouyouka AG, Marin ML, Faries PL. The success of endovascular therapy for all TransAtlantic Society Consensus graded femoropopliteal lesions. Ann Vasc Surg 2011; 25 (01) 15-24
    CrossrefPubMedGoogle Scholar
  • 14 Markose G, Miller FN, Bolia A. Subintimal angioplasty for femoro-popliteal occlusive disease. J Vasc Surg 2010; 52 (05) 1410-1416
    CrossrefPubMedGoogle Scholar
  • 15 Met R, Van Lienden KP, Koelemay MJ, Bipat S, Legemate DA, Reekers JA. Subintimal angioplasty for peripheral arterial occlusive disease: a systematic review. Cardiovasc Intervent Radiol 2008; 31 (04) 687-697
    CrossrefPubMedGoogle Scholar
  • 16 Spinosa DJ, Harthun NL, Bissonette EA. , et al. Subintimal arterial flossing with antegrade-retrograde intervention (SAFARI) for subintimal recanalization to treat chronic critical limb ischemia. J Vasc Interv Radiol 2005; 16 (01) 37-44
    CrossrefPubMedGoogle Scholar
  • 17 Michael TT, Papayannis AC, Banerjee S, Brilakis ES. Subintimal dissection/reentry strategies in coronary chronic total occlusion interventions. Circ Cardiovasc Interv 2012; 5 (05) 729-738
    CrossrefPubMedGoogle Scholar
  • 18 Matsumi J, Ochiai T, Tobita K. , et al. Long-term outcomes of self-expandable nitinol stent implantation with intraluminal angioplasty to treat chronic total occlusion in the superficial femoral artery (TransAtlantic Inter-Society Consensus Type D Lesions). J Invasive Cardiol 2016; 28 (02) 58-64
    PubMedGoogle Scholar
  • 19 Zeller T, Rastan A, Macharzina R. , et al. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions. J Endovasc Ther 2014; 21 (03) 359-368
    CrossrefPubMedGoogle Scholar
  • 20 Hong SJ, Ko YG, Shin DH. , et al. Outcomes of spot stenting versus long stenting after intentional subintimal approach for long chronic total occlusions of the femoropopliteal artery. JACC Cardiovasc Interv 2015; 8 (03) 472-480
    CrossrefPubMedGoogle Scholar
  • 21 Geraghty PJ, Mewissen MW, Jaff MR, Ansel GM. ; VIBRANT Investigators. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease. J Vasc Surg 2013; 58 (02) 386-95.e4
    CrossrefPubMedGoogle Scholar
  • 22 Garcia L, Jaff MR, Metzger C. , et al; SUPERB Trial Investigators. Wire-interwoven nitinol stent outcome in the superficial femoral and proximal popliteal arteries: twelve-month results of the SUPERB trial. Circ Cardiovasc Interv 2015; 8 (05) e000937
    PubMedGoogle Scholar
  • 23 Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 2000; 101 (05) 570-580
    CrossrefPubMedGoogle Scholar
  • 24 Mendes BC, Oderich GS, Fleming MD. , et al. Clinical significance of embolic events in patients undergoing endovascular femoropopliteal interventions with or without embolic protection devices. J Vasc Surg 2014; 59 (02) 359-367.e1
    CrossrefPubMedGoogle Scholar
  • 25 Shrikhande GV, Khan SZ, Hussain HG, Dayal R, McKinsey JF, Morrissey N. Lesion types and device characteristics that predict distal embolization during percutaneous lower extremity interventions. J Vasc Surg 2011; 53 (02) 347-352
    CrossrefPubMedGoogle Scholar
  • 26 Davies MG, Bismuth J, Saad WE. , et al. Implications of in situ thrombosis and distal embolization during superficial femoral artery endoluminal intervention. Ann Vasc Surg 2010; 24 (01) 14-22
    CrossrefPubMedGoogle Scholar
  • 27 Shammas NW, Dippel EJ, Coiner D, Shammas GA, Jerin M, Kumar A. Preventing lower extremity distal embolization using embolic filter protection: results of the PROTECT registry. J Endovasc Ther 2008; 15 (03) 270-276
    CrossrefPubMedGoogle Scholar
  • 28 Ward TJ, Piechowiak RL, Patel RS. , et al. Revascularization for critical limb ischemia using the SpiderFX embolic protection device in the below-the-knee circulation: initial results. J Vasc Interv Radiol 2014; 25 (10) 1533-1538
    CrossrefPubMedGoogle Scholar
  • 29 Jia Z, Zhao J, Tian F. , et al. Use of spider filter embolic protection device during endovascular revascularization of acute thromboembolic occlusion of superficial femoral artery. Cardiovasc Intervent Radiol 2015; 38 (06) 1444-1450
    CrossrefPubMedGoogle Scholar